jeudi 8 septembre 2016

Onco Actu du 8 septembre 2016

4. Dépistage, diagnostic et pronostic

Infra-red light to detect early signs of oesophageal cancer [Cancer Research UK]

4.11 Dép., diag. & prono. - Ovaire

FDA warns against widely used ovarian cancer screening test [STAT]

The FDA recommends against using screening tests for ovarian cancer screening: FDA Safety Communication [FDA]

4.13 Dép., diag. & prono. - Peau

Nanotechnology Supports Treatment of Malignant Melanoma [University of Basel]

4.5 Dép., diag. & prono. - Colorectal

Single-letter variation in DNA linked to longer bowel cancer survival [The Institute of Cancer Research]

5. Traitements

Approach May Allow for Stem Cell Transplant without Radiation, Chemotherapy [NCI]

5.12 Immunothérapies

With Opdivo in its sights, Merck's Keytruda nabs breakthrough tag in first-line lung cancer [FiercePharma]

FDA Accepts Supplemental Biologics License Application, Assigns Priority Review and Grants Breakthrough Therapy Designation to Merck’s KEYTRUDA® (pembrolizumab) for First-Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer [Merck]

Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches [Xconomy]

5.12.1 Immunothérapies - partenariats

Genentech, BioLineRx pair up a checkpoint inhibitor combo [FierceBiotech]

5.12.2 Immunothérapies - CAR-T

Clinical Data Published in Science Translational Medicine: Patients with Advanced Lymphoma in Remission after T-cell Therapy [Juno]

5.2.1 Pharma - Partenariats

Agios Blood Cancer Drug Heading to Early FDA Filing by Partner Celgene [The Street]

5.3 Traitements - FDA, EMA,...

Workshop on adaptive pathways - discussing a concept for development of medicines addressing unmet medical needs [EMA]

FDA slams drug maker for touting unapproved leukemia treatment to docs [STAT]

5.4 Traitements - Economie

Fixing Drug Pricing Means Paying For “Value” [The Incidental Economist]

6. Lutte contre les cancers

Improving care for cancer patients in Northern Ireland [Cancer Research UK]

6.10.1 Politiques (USA)

AACR Embraces Cancer Moonshot Blue Ribbon Panel’s Recommendations [AACR]

ASCO Applauds Bold Recommendations from Cancer Moonshot Blue Ribbon Panel [ASCO]

Top scientists lay out sweeping recommendations for ‘moonshot’ against cancer [STAT]

Cancer Moonshot Panel Details Necessary Steps to Accelerate Cancer Research and Prevention [ACS]

Blue ribbon report urges U.S. cancer moonshot to invest in 10 promising areas [Science]

Cancer experts unveil wishlist for US government ‘moonshot’ [Nature]

Blue Ribbon Panel 2016 [NCI]

NCI’s Moonshot Advisory Panel Identifies Ten Opportunities in Cancer Research [The Cancer Letter]

'Moonshot' cancer panel calls for US to create national research database [The Guardian]